Maria Themeli

9PUBLICATIONS
40CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Organised crimeCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 14, 2026
T cells dressed up with a dual HLA-restricted TCR targeting cathepsin G drive effective AML eradication.

Francesca Marzuttini, Alessia Potenza, Ludovica Celli

|Aug 21, 2025
A burden too high for CAR T cells in CLL.

Arnon P Kater, Maria Themeli

|Jul 26, 2024
Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma.

Charlotte L B M Korst, Chloe O'Neill, Wassilis S C Bruins

|Aug 01, 2023
Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138.

Jort J van der Schans, Ziyu Wang, Jennemiek van Arkel

|Dec 22, 2022
Selecting CD7- T cells for CAR T-cell therapy.

Maria Themeli

|May 16, 2022
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models.

Emmanuel Donnadieu, Maik Luu, Miriam Alb

Pageof 2

Frequent Collaborators

3 joint publications

Sonja Zweegman

2 joint publications

Afroditi Katsarou

2 joint publications

Richard W J Groen

2 joint publications

Huipin Yuan